Gravitas Feeding Tube System Placement in Neonates
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304
- Lucile Packard Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Infants in the Newborn Intensive Care Unit requiring a 5Fr NG tube. The desired size of the feeding tube should be determined clinically, and the Gravitas 5Fr Feeding Tube should only be placed if that size is appropriate.
Inclusion Criteria:
- Age at enrollment: 0 to 18 weeks post-partum. Can be up to 12 weeks preterm (gestational age ≥ 28 weeks).
- Suitable to start enteral feeding
- Anticipated to receive enteral feeding (either bolus or continuous feeds) for more than 6 hours and conclude the enteral nutrition while in the care of the NICU. If enteral nutrition has already been initiated, indicated for replacement of an orogastric/nasogastric feeding tube.
Exclusion Criteria:
- Known major upper airway malformation (e.g. tracheoesophageal fistula)
- Known major GI malformation (e.g. malrotation)
- NPO status -neonate expected to remain NPO for the following 72 hours
- Has a medical condition that drastically affects gastric acid-secretion (e.g. Zollinger-Ellison Syndrome, congenital achlorhydria, gastrointestinal perforation/leak/obstruction)
- Has had removal of part of the stomach
- Critically ill, facing imminent death
- Neonate on ECMO
- Deemed unsuitable for enrollment in study by the site principal investigator based on the patients' medical history
- Ability to have a legally authorized representative provide informed consent
Both neonates on a ventilator (non-invasive or invasive ventilation) or not requiring a ventilator are eligible for this study.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Nasogastric tube group
Neonates age 0-18 weeks post-partum at enrollment with gestational age > 28 weeks will have the Gravitas Feeding Tube placed using standard technique.
Tube placement will be verified by the institution standard of care.
Study tubes are to remain in place up to 30 days.
|
Temperature and impedance data will be collected from sensors embedded within the feeding tube wall.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of accurate verifications of anatomical locations of the tip of the Gravitas feeding tube.
Time Frame: 5 months
|
Data collected during the study will be post processed to refine the Gravitas placement algorithm.
The position of the feeding tube tip as processed by the Gravitas placement algorithm will be compared to institutional standard of care.
|
5 months
|
|
Percentage of accurate removals/dislodgements identified by the Gravitas dislodgement algorithm.
Time Frame: 5 months
|
Data collected during the study will be post processed to refine the Gravitas placement algorithm.
The removal/dislodgement of the feeding tube tip as processed by the Gravitas placement algorithm will be compared to actual removal/verification of dislodgement by institutional standard of care.
|
5 months
|
|
Adverse events (a) related to placement and (b) throughout the duration of the presence of the feeding tube within the patient.
Time Frame: 5 months
|
The number and type of adverse events will be collected.
|
5 months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- CRD-04-1493
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.